NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger
"I am delighted to join NAYA Biosciences upon the closing of its public merger," commented Dr. Peter Kash.
- "I am delighted to join NAYA Biosciences upon the closing of its public merger," commented Dr. Peter Kash.
- "We welcome Peter to NAYA's board as we close our public merger with INVO and prepare to execute an ambitious growth strategy," added Dr. Daniel Teper, Chairman and CEO of NAYA Biosciences.
- He is currently the cofounder and Vice Chairman of TargImmune Therapeutics (Switzerland) and cofounder and Managing Director of Camelot BioCapital.
- Dr. Kash completed post graduate classes on Making Boards of Directors More Effective at Harvard Business School.